1. Home
  2. ORKA vs CRMT Comparison

ORKA vs CRMT Comparison

Compare ORKA & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKA
  • CRMT
  • Stock Information
  • Founded
  • ORKA 2004
  • CRMT 1981
  • Country
  • ORKA United States
  • CRMT United States
  • Employees
  • ORKA N/A
  • CRMT N/A
  • Industry
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CRMT Other Specialty Stores
  • Sector
  • ORKA Health Care
  • CRMT Consumer Discretionary
  • Exchange
  • ORKA Nasdaq
  • CRMT Nasdaq
  • Market Cap
  • ORKA 429.4M
  • CRMT 375.4M
  • IPO Year
  • ORKA N/A
  • CRMT N/A
  • Fundamental
  • Price
  • ORKA $8.92
  • CRMT $44.62
  • Analyst Decision
  • ORKA Strong Buy
  • CRMT Hold
  • Analyst Count
  • ORKA 7
  • CRMT 3
  • Target Price
  • ORKA $39.67
  • CRMT $50.00
  • AVG Volume (30 Days)
  • ORKA 272.6K
  • CRMT 94.9K
  • Earning Date
  • ORKA 03-06-2025
  • CRMT 03-06-2025
  • Dividend Yield
  • ORKA N/A
  • CRMT N/A
  • EPS Growth
  • ORKA N/A
  • CRMT N/A
  • EPS
  • ORKA N/A
  • CRMT 1.04
  • Revenue
  • ORKA N/A
  • CRMT $1,380,231,000.00
  • Revenue This Year
  • ORKA N/A
  • CRMT $1.01
  • Revenue Next Year
  • ORKA N/A
  • CRMT $4.13
  • P/E Ratio
  • ORKA N/A
  • CRMT $42.80
  • Revenue Growth
  • ORKA N/A
  • CRMT N/A
  • 52 Week Low
  • ORKA $8.66
  • CRMT $36.40
  • 52 Week High
  • ORKA $53.88
  • CRMT $72.26
  • Technical
  • Relative Strength Index (RSI)
  • ORKA N/A
  • CRMT 44.77
  • Support Level
  • ORKA N/A
  • CRMT $43.41
  • Resistance Level
  • ORKA N/A
  • CRMT $47.81
  • Average True Range (ATR)
  • ORKA 0.00
  • CRMT 2.19
  • MACD
  • ORKA 0.00
  • CRMT -0.12
  • Stochastic Oscillator
  • ORKA 0.00
  • CRMT 34.12

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: